News

Novo Nordisk applies for FDA approval in tightening race for weight loss pill
Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to ...
Should You Buy The Current Dip In Novo Nordisk Stock?
Novo Nordisk (NYSE:NVO) stock has experienced a significant decline, dropping 35% from over $90 in early March to around $58 ...